PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human CCL8 (MCP-2) (carrier-free), 10 μg
Recombinant Human CCL8 (MCP-2) (carrier-free), 100 μg
Recombinant Human CCL8 (MCP-2) (carrier-free), 25 μg
Recombinant Human CD14 (carrier-free), 10 μg
Recombinant Human CD14 (carrier-free), 100 μg
Recombinant Human CD14 (carrier-free), 25 μg
Recombinant Human CD27L (carrier-free), 25 μg
Recombinant Human CD28-Fc Chimera (carrier-free), 100 μg
Recombinant Human CD40L (TNFSF5) (Animal-Free), 50 μg
Recombinant Human CD40L (TNFSF5) (carrier-free), 10 μg
Recombinant Human CD40L (TNFSF5) (carrier-free), 100 μg
Recombinant Human CD40L (TNFSF5) (carrier-free), 25 μg
Recombinant Human CD40L (TNFSF5) (carrier-free), 500 μg
Recombinant Human Clusterin (carrier-free), 10 µg
Recombinant Human Clusterin (carrier-free), 100 µg
Recombinant Human Clusterin (carrier-free), 25 µg